Skip to content

Author

Alfred I. Neugut

We have 3 of 46 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Determinants of prostate-specific antigen levels in African men

Abstract Background Prostate-specific antigen (PSA) is widely used for screening and diagnosis of prostate cancer. Variation in PSA levels is influenced by age, genetics, and other factors, yet this variation has not been well characterized in African men. Methods We used data on serum PSA extracted from medical record...

Eunsoo Cho, I. Agalliu, Thomas E. Rohan et al. · 0 citations
Open access Sep 2026

Indication-specific adverse event profiles of semaglutide and liraglutide: a FAERS disproportionality analysis

Objective By 2021, regulatory agencies had approved two glucagon-like peptide-1 receptor agonists (GLP-1RAs), semaglutide and liraglutide, for the treatment of type 2 diabetes and obesity. Since then, concerns have emerged about whether adverse events (AEs) differ by GLP-1RA or indication. Research design and methods W...

Samuel A. Fisch, Eitan J. Neugut, Nicole Cornet et al. · 0 citations
Aug 2026

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

PURPOSE Age ≥40 years is regarded as a high-risk feature and an indication for adjuvant chemoradiotherapy for patients with lower-grade glioma in clinical practice guidelines. It is unclear whether age remains a relevant prognostic factor for contemporary definitions of lower-grade gliomas in the molecular era. METHO...

C. Kinslow, G. Minniti, P. Brown et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.